Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3895 EUR | -0.13% | -3.83% | -15.33% |
05-07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
04-05 | GenSight: financial visibility assured until the end of April | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.33% | 42.86M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Gets EUR10 Million Funding, Extends Cash Runway to October; Shares Down 14%